Indication
Details coming soon
Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adults |
Dose: Reconstituted vaccine – 0.5 ml Frequency: Single dose Note: Given by deep subcutaneous injection into the outer aspect of arm. Do not give intravenously. |
|
Age: Toddlers |
Dose: Reconstituted vaccine – 0.5 ml Frequency: Single dose Note: Given by deep subcutaneous injection into the anterolateral aspect of upper thigh. Do not give intravenously. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Toddlers |
Dose: Reconstituted vaccine – 0.5 ml Note: single dose given by deep subcutaneous injection into the anterolateral aspect of upper thigh; Do not give intravenously |
|
Age: Older children and adults |
Dose: Reconstituted vaccine – 0.5 ml Note: single dose given by deep subcutaneous injection into the outer aspect of arm; Do not give intravenously |
Administration
- Give deep subcutaneous injection
- Give in upper arm or thigh
Side Effect
- Generally pain and tenderness at the injection site may occur within 24 hours after vaccination
- which usually disappear by itself within 2-3 days
- Generally transient fever reaction may occur within 1-2 weeks after vaccination
- Rash generally mild rash may occur within 12 days after vaccination
- which generally lasts for no more than 2 days
- Severe fever reaction physical methods and drugs should be used for symptomatic treatment to prevent febrile seizures
- Allergic rash generally urticaria may occur within 72 hours after vaccination
- and if this reaction occurs
- anti-allergy treatment should be timely given
- Anaphylactic shock generally occurs within 1 hour after vaccination
- Injection of epinephrine and other emergency measures should be timely given for treatment
- Anaphylactoid purpura medical care should be timely given if anaphylactoid purpura occurs
- Cortical steroids can be given for anti-allergy treatment
- Improper or not timely treatment is likely to cause anaphylatic purpura nephritis
- Thrombocytopenia purpura
- Adults may develop arthritis
- pain and swelling of large joints after vaccination
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Immunoglobulins (Various specific types)
|
Affected by
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Blood System Disorders
|
Risk of complications
|
|
Vaccine Component Allergy
|
Risk of severe allergic reaction
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep out of the reach and sight of children. Store at +2°C to +8°C. Transportation should also be at +2°C to +8°C. Do not freeze. Discard vaccine if frozen. Protect from light.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.